Shepherd Kaplan Krochuk’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,500
| Closed | -$681K | – | 90 |
|
|
2022
Q3 | $681K | Hold |
1,500
| – | – | 0.34% | 58 |
|
|
2022
Q2 | $724K | Hold |
1,500
| – | – | 0.32% | 59 |
|
|
2022
Q1 | $737K | Hold |
1,500
| – | – | 0.28% | 61 |
|
|
2021
Q4 | $695K | Hold |
1,500
| – | – | 0.25% | 65 |
|
|
2021
Q3 | $559K | Hold |
1,500
| – | – | 0.21% | 85 |
|
|
2021
Q2 | $573K | Sell |
1,500
-200
| -12% | -$76.4K | 0.2% | 83 |
|
|
2021
Q1 | $610K | Sell |
1,700
-600
| -26% | -$193K | 0.24% | 69 |
|
|
2020
Q4 | $739K | Sell |
2,300
-100
| -4% | -$30.7K | 0.27% | 63 |
|
|
2020
Q3 | $645K | Hold |
2,400
| – | – | 0.27% | 61 |
|
|
2020
Q2 | $631K | Hold |
2,400
| – | – | 0.28% | 66 |
|
|
2020
Q1 | $545K | Sell |
2,400
-1,530
| -39% | -$417K | 0.88% | 30 |
|
|
2019
Q4 | $1.19M | Hold |
3,930
| – | – | 0.9% | 28 |
|
|
2019
Q3 | $944K | Hold |
3,930
| – | – | 0.69% | 36 |
|
|
2019
Q2 | $1.11M | Hold |
3,930
| – | – | 0.78% | 31 |
|
|
2019
Q1 | $1.13M | Hold |
3,930
| – | – | 0.7% | 33 |
|
|
2018
Q4 | $1.03M | Sell |
3,930
-1,000
| -20% | -$275K | 0.71% | 35 |
|
|
2018
Q3 | $1.35M | Hold |
4,930
| – | – | 0.7% | 30 |
|
|
2018
Q2 | $1.17M | Hold |
4,930
| – | – | 0.71% | 32 |
|
|
2018
Q1 | $1.08M | Hold |
4,930
| – | – | 0.66% | 36 |
|
|
2017
Q4 | $1.11M | Sell |
4,930
-400
| -8% | -$85.2K | 0.69% | 37 |
|
|
2017
Q3 | $1.01M | Hold |
5,330
| – | – | 0.84% | 30 |
|
|
2017
Q2 | $1M | Sell |
5,330
-1,000
| -16% | -$180K | 0.58% | 41 |
|
|
2017
Q1 | $1.05M | Hold |
6,330
| – | – | 0.54% | 41 |
|
|
2016
Q4 | $910K | Sell |
6,330
-2,177
| -26% | -$291K | 0.26% | 51 |
|
|
2016
Q3 | $1.07M | Hold |
8,507
| – | – | 0.22% | 57 |
|
|
2016
Q2 | $1.12M | Hold |
8,507
| – | – | 0.28% | 59 |
|
|
2016
Q1 | $1.18M | Buy |
8,507
+14
| +0.2% | +$1.87K | 0.37% | 47 |
|
|
2015
Q4 | $1.18M | Buy |
8,493
+360
| +4% | +$49.6K | 0.31% | 52 |
|
|
2015
Q3 | $1.14M | Sell |
8,133
-2,490
| -23% | -$374K | 0.3% | 54 |
|
|
2015
Q2 | $1.74M | Buy |
10,623
+430
| +4% | +$68.7K | 0.33% | 49 |
|
|
2015
Q1 | $1.57M | Sell |
10,193
-711
| -7% | -$101K | 0.28% | 58 |
|
|
2014
Q4 | $1.37M | Buy |
10,904
+1,068
| +11% | +$132K | 0.22% | 93 |
|
|
2014
Q3 | $1.18M | Sell |
9,836
-717
| -7% | -$82.2K | 0.15% | 111 |
|
|
2014
Q2 | $1.14M | Hold |
10,553
| – | – | 0.12% | 128 |
|
|
2014
Q1 | $1.05M | Hold |
10,553
| – | – | 0.12% | 135 |
|
|
2013
Q4 | $975K | Sell |
10,553
-364
| -3% | -$32.3K | 0.12% | 144 |
|
|
2013
Q3 | $913K | Hold |
10,917
| – | – | 0.15% | 136 |
|
|
2013
Q2 | $893K | Buy |
+10,917
| New | +$817K | 0.18% | 123 |
|
Other funds holding ELV
Shepherd Kaplan Krochuk's ELV Position: Q4 2022 in Review
Shepherd Kaplan Krochuk sold out of Elevance Health (ELV) in Q4 2022, closing a stake of 1,500 shares — an estimated $681K sold.
Shepherd Kaplan Krochuk first reported a position in ELV in Q2 2013 and held it in 38 quarters. The position peaked at $1.74M in Q2 2015. 1,548 funds tracked by Wall St. Rank hold ELV as of Q4 2022.
- Shepherd Kaplan Krochuk reported no remaining Elevance Health position as of Q4 2022 after selling out during the quarter.
- Shepherd Kaplan Krochuk sold 1,500 Elevance Health shares in Q4 2022, an estimated $681K.
- Shepherd Kaplan Krochuk first reported a position in Elevance Health in Q2 2013 and held it in 38 quarters.
- Shepherd Kaplan Krochuk's Elevance Health position peaked at $1.74M in Q2 2015.
- 1,548 funds tracked by Wall St. Rank held Elevance Health as of Q4 2022.
Based on Shepherd Kaplan Krochuk's 13F filing for Q4 2022, filed 14 Feb 2023.